{"pageContent": "Objectives: To analyse the perioperative and oncological outcomes of all radical prostatectomies (RPs) performed for high-risk prostate cancer in the British Association of Urological Surgeons (BAUS) national registry from 2014 to 2015.", "metaData": {"source": "Using surrogate biomarkers to predict clinical benefit in men with castration-resistant prostate cancer: an update and review of the literature\nhttps://pubmed.ncbi.nlm.nih.gov/19684076/"}}